5-09-2024, 21:52

Boehringer Ingelheim announces plans to advance potential new treatment for Geographic Atrophy, following positive Phase I results
Globe Newswire5-09-2024, 21:52
13-02-2023, 19:03

ONL Therapeutics to Present at the XXVth Biennial Meeting

Oral presentation will review the scientific rationale for Fas receptor inhibition, a unique mechanism-of-action, in
Globe Newswire13-02-2023, 19:03
2-02-2023, 19:05

ONL Therapeutics to Present at 2023 BIO CEO & Investor

ANN ARBOR, Mich., Feb. 02, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company
Globe Newswire2-02-2023, 19:05
31-01-2023, 19:00

Eyenuk Secures the First European Union MDR Certification for Autonomous AI Detection of Diabetic Retinopathy, Age-Related Macular Degeneration, and Glaucoma
Globe Newswire31-01-2023, 19:00